Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 260 | 2 | 248 | −10 |
| Shares | 87.9M | 20.5K | 82.4M | −5.47M (−6.2%) |
| Value | $1.47B | $339.7K | $1.11B | −$364.0M (−24.7%) |
2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (46)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (2)
Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Kula Investments, LLC | 20,488 | $339.7K |
| Ahrens Investment Partners LLC | 1 | $17 |